1. Hyoscine hydrobromide patches: risk of anticholinergic side effects

   Unknown 05 August 2023 Pages: 1 - 1

2. Leptospirosis vaccine-related AEs

   News item 05 August 2023 Pages: 2 - 2

3. Monkeypox vaccination-related AEs

   Clinical study 05 August 2023 Pages: 3 - 3

4. AEFIs after intradermal monkeypox vaccination

   Epidemiology clinical study 05 August 2023 Pages: 4 - 4

5. Antibacterial-related Clostridium difficile infection

   Epidemiology clinical study 05 August 2023 Pages: 5 - 5

6. ARs caused by lenvatinib plus pembrolizumab

   Clinical study 05 August 2023 Pages: 6 - 6

7. Combined paclitaxel or nab-PTX and ICIs reduces risk of irAEs

   Review 05 August 2023 Pages: 7 - 7

8. GLP-1RAs may cause intolerable gastrointestinal AEs

   Review 05 August 2023 Pages: 8 - 8

9. Oncology biosimilars and originators have similar safety profiles

   Epidemiology clinical study 05 August 2023 Pages: 9 - 9

10. Prescription drug-induced delusion

    Epidemiology clinical study 05 August 2023 Pages: 10 - 10

11. Risankizumab-related serious ARs in patients with psoriasis

    Epidemiology clinical study 05 August 2023 Pages: 11 - 11

12. SSRI treatment increases risk of rhabdomyolysis

    Epidemiology population study 05 August 2023 Pages: 12 - 12

13. Other adverse reaction research

    News item 05 August 2023 Pages: 13 - 13

14. Abemaciclib/fulvestrant/palbociclib

    Case report 05 August 2023 Pages: 14 - 14

15. Abiraterone

    Case report 05 August 2023 Pages: 15 - 15

16. Acam-2000/smallpox-vaccine

    Case report 05 August 2023 Pages: 16 - 16

17. Adalimumab

    Case report 05 August 2023 Pages: 17 - 17

18. Adalimumab

    Case report 05 August 2023 Pages: 18 - 18

19. Adalimumab

    Case report 05 August 2023 Pages: 19 - 19

20. Alectinib/famotidine interaction

    Case report 05 August 2023 Pages: 20 - 20

21. Alpelisib

    Case report 05 August 2023 Pages: 21 - 21

22. Aminoglycoside/ceftriaxone

    Case report 05 August 2023 Pages: 22 - 22

23. Amitriptyline

    Case report 05 August 2023 Pages: 23 - 23

24. Amphotericin B

    Case report 05 August 2023 Pages: 24 - 24

25. Amphotericin-B

    Case report 05 August 2023 Pages: 25 - 25

26. Amphotericin-B/itraconazole/voriconazole

    Case report 05 August 2023 Pages: 26 - 26

27. Anaesthetics

    Case report 05 August 2023 Pages: 27 - 27

28. Anakinra

    Case report 05 August 2023 Pages: 28 - 28

29. Anti-infectives

    Case report 05 August 2023 Pages: 29 - 29

30. Antibacterials

    Case report 05 August 2023 Pages: 30 - 30

31. Antibacterials

    Case report 05 August 2023 Pages: 31 - 31

32. Antiepileptic drugs

    Case report 05 August 2023 Pages: 32 - 32

33. Antiepileptic drugs

    Case report 05 August 2023 Pages: 33 - 33

34. Antiepileptics

    Case report 05 August 2023 Pages: 34 - 34

35. Antineoplastic

    Case report 05 August 2023 Pages: 35 - 35

36. Antineoplastic drugs

    Case report 05 August 2023 Pages: 36 - 36

37. Antineoplastics

    Case report 05 August 2023 Pages: 37 - 37

38. Antineoplastics

    Case report 05 August 2023 Pages: 38 - 38

39. Antineoplastics

    Case report 05 August 2023 Pages: 39 - 39

40. Antineoplastics

    Case report 05 August 2023 Pages: 40 - 40

41. Antineoplastics

    Case report 05 August 2023 Pages: 41 - 41

42. Antineoplastics

    Case report 05 August 2023 Pages: 42 - 42

43. Antineoplastics

    Case report 05 August 2023 Pages: 43 - 43

44. Antineoplastics

    Case report 05 August 2023 Pages: 44 - 44

45. Antineoplastics/antithymocyte-globulin

    Case report 05 August 2023 Pages: 45 - 45

46. Antineoplastics/methylprednisolone

    Case report 05 August 2023 Pages: 46 - 46

47. Antiplatelets/tirofiban

    Case report 05 August 2023 Pages: 47 - 47

48. Antipsychotics/valproate

    Case report 05 August 2023 Pages: 48 - 48

49. Antituberculars

    Case report 05 August 2023 Pages: 49 - 49

50. Antituberculars

    Case report 05 August 2023 Pages: 50 - 50